Bench-to-bedside: NIMH research leads to brexanolone, first-ever drug specifically for postpartum depression

Approximately 1 in 9 women in the United States experiences symptoms.

From https://www.nih.gov/news-events/news-releases/bench-bedside-nimh-research-leads-brexanolone-first-ever-drug-specifically-postpartum-depression

from
https://healthnews010.wordpress.com/2019/03/21/bench-to-bedside-nimh-research-leads-to-brexanolone-first-ever-drug-specifically-for-postpartum-depression/

from https://karlfletcher.blogspot.com/2019/03/bench-to-bedside-nimh-research-leads-to.html

from
https://karlfletcher1.tumblr.com/post/183601645888